Example: Heart Attack

Clinical Trials Sponsored by Cypress Bioscience, Inc.

Total 7 results

NCT01328002

Terminated

Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia

Conditions: Primary Fibromyalgia
NCT01331109

Terminated

Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia

Conditions: Primary Fibromyalgia
NCT01077375

Completed

Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia

Conditions: Fibromyalgia
NCT01014585

Completed

Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia

Conditions: Fibromyalgia
NCT01038349

Completed

Applications for Methotrexate Optimization in Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis
NCT00314249

Completed

Study of Milnacipran for the Treatment of Fibromyalgia

Conditions: Fibromyalgia
NCT00618956

Completed

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

Conditions: Fibromyalgia